Paper34239306
Circular RNAs Regulate Glucose Metabolism in Cancer Cells.
Ji X and 4 others. Onco Targets Ther, 2021. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Circular RNAs Regulate Glucose Metabolism in Cancer Cells. Papers, record 34239306. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34239306
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References192
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27573352 | TSC22D2 interacts with PKM2 and inhibits cell growth in colorectal cancer. | Int J Oncol | 2016 | https://conductscience.org/library/papers/27573352 | PubMed |
| 2 | 19861459 | MYC-induced cancer cell energy metabolism and therapeutic opportunities. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19861459 | PubMed |
| 3 | 21177384 | Mitochondrial and plasma membrane lactate transporter and lactate dehydrogenase isoform expression in breast cancer cell lines. | Physiol Genomics | 2011 | https://conductscience.org/library/papers/21177384 | PubMed |
| 4 | 32673066 | Circular RNA circ_0091579 Promotes Hepatocellular Carcinoma Proliferation, Migration, Invasion, and Glycolysis Through miR-490-5p/CASC3 Axis. | Cancer Biother Radiopharm | 2021 | https://conductscience.org/library/papers/32673066 | PubMed |
| 5 | 7499431 | Diversity of the pyruvate dehydrogenase kinase gene family in humans. | J Biol Chem | 1995 | https://conductscience.org/library/papers/7499431 | PubMed |
| 7 | 32943922 | Exosomal Circ-ZNF652 Promotes Cell Proliferation, Migration, Invasion and Glycolysis in Hepatocellular Carcinoma via miR-29a-3p/GUCD1 Axis. | Cancer Manag Res | 2020 | https://conductscience.org/library/papers/32943922 | PubMed |
| 9 | 27337956 | Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2. | Tumour Biol | 2016 | https://conductscience.org/library/papers/27337956 | PubMed |
| 10 | 32987339 | Circular RNAs: New players in thyroid cancer. | Pathol Res Pract | 2020 | https://conductscience.org/library/papers/32987339 | PubMed |
| 11 | 25242144 | circRNA biogenesis competes with pre-mRNA splicing. | Mol Cell | 2014 | https://conductscience.org/library/papers/25242144 | PubMed |
| 12 | 21813754 | Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality. | Sci Transl Med | 2011 | https://conductscience.org/library/papers/21813754 | PubMed |
| 13 | 32496549 | Silencing circSLAMF6 represses cell glycolysis, migration, and invasion by regulating the miR-204-5p/MYH9 axis in gastric cancer under hypoxia. | Biosci Rep | 2020 | https://conductscience.org/library/papers/32496549 | PubMed |
| 14 | 26734996 | Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest. | Oncotarget | 2016 | https://conductscience.org/library/papers/26734996 | PubMed |
| 15 | 24646661 | Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling. | Mol Syst Biol | 2014 | https://conductscience.org/library/papers/24646661 | PubMed |
| 16 | 32821160 | circ_0136666 Facilitates the Progression of Colorectal Cancer via miR-383/CREB1 Axis. | Cancer Manag Res | 2020 | https://conductscience.org/library/papers/32821160 | PubMed |
| 17 | 24140020 | mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc. | Cell Metab | 2013 | https://conductscience.org/library/papers/24140020 | PubMed |
| 18 | 33880589 | circ-PRKCI targets miR-1294 and miR-186-5p by downregulating FOXK1 expression to suppress glycolysis in hepatocellular carcinoma. | Mol Med Rep | 2021 | https://conductscience.org/library/papers/33880589 | PubMed |
| 19 | 15650020 | Akt activation is required at a late stage of insulin-induced GLUT4 translocation to the plasma membrane. | Mol Endocrinol | 2005 | https://conductscience.org/library/papers/15650020 | PubMed |
| 20 | 25664725 | Exon-intron circular RNAs regulate transcription in the nucleus. | Nat Struct Mol Biol | 2015 | https://conductscience.org/library/papers/25664725 | PubMed |
| 21 | 27886165 | Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity. | Cell Death Differ | 2017 | https://conductscience.org/library/papers/27886165 | PubMed |
| 22 | 31814891 | Hypoxia-induced circular RNA has_circRNA_403658 promotes bladder cancer cell growth through activation of LDHA. | Am J Transl Res | 2019 | https://conductscience.org/library/papers/31814891 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41596634 | CircRNAs in Immuno-Metabolic Reprogramming of Chordoma Cancer: Molecular Crosstalk and Therapeutic Potential. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596634 | PubMed |
| 40573210 | Warburg-like Metabolic Reprogramming in Endometriosis: From Molecular Mechanisms to Therapeutic Approaches. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40573210 | PubMed |
| 38951482 | CircABHD2 Inhibits Malignant Progression of Endometrial Cancer by Regulating NAD+/NAMPT Metabolism Axis. | Mol Biotechnol | 2025 | https://conductscience.org/library/papers/38951482 | PubMed |
| 38586314 | Unraveling the crosstalk: circRNAs and the wnt signaling pathway in cancers of the digestive system. | Noncoding RNA Res | 2024 | https://conductscience.org/library/papers/38586314 | PubMed |
| 37599427 | Research progress of circRNA in malignant tumour metabolic reprogramming. | RNA Biol | 2023 | https://conductscience.org/library/papers/37599427 | PubMed |
| 37204526 | Non-coding RNAs in breast cancer: with a focus on glucose metabolism reprogramming. | Discov Oncol | 2023 | https://conductscience.org/library/papers/37204526 | PubMed |
| 34869036 | A Novel Microcrystalline BAY-876 Formulation Achieves Long-Acting Antitumor Activity Against Aerobic Glycolysis and Proliferation of Hepatocellular Carcinoma. | Front Oncol | 2021 | https://conductscience.org/library/papers/34869036 | PubMed |
Genes77
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34239306
GET https://conductscience.org/api/papers/v1/34239306/references?page=2